Colorectal Cancer and Obesity
Bowel cancer is one of the cancers most strongly linked to excess weight, especially fat around the waist - and screening finds it early, when it is curable.
Plain English
Patient-Friendly Explanation
Colorectal cancer - cancer of the colon or rectum - is one of several cancers whose risk rises with body weight. The link is strongest for fat carried around the waist and for men, and it is thought to work through several pathways at once: higher insulin and growth-factor signals encourage cells to multiply, fat tissue releases inflammatory signals, and the bile acids and gut bacteria of people carrying excess weight create an environment more favourable to polyps and tumours. Because early bowel cancer usually causes no symptoms at all, screening matters more than symptoms. In Singapore this means a faecal immunochemical test (FIT) or colonoscopy in average-risk adults from age 50, and earlier where there is a family history, blood in the stool, unexplained weight loss or anaemia. The same measures that help weight - more fibre, whole grains and vegetables, less processed and red meat, less alcohol, and regular activity - also lower bowel cancer risk, so the plan for one helps the other.
Medical
Clinical Definition
Obesity is an established, dose-dependent risk factor for colorectal cancer (CRC). Meta-analyses place the relative risk at roughly 1.2 to 1.5 for BMI of 30 or above compared with normal weight, with a larger effect in men (approximately 1.4 to 1.5) than in women and a stronger association for colon than rectal cancer; abdominal adiposity is associated with CRC independently of BMI, and waist circumference shows a graded relationship with risk. Proposed mechanisms include chronic hyperinsulinaemia with increased insulin and IGF-1 receptor signalling, which promotes cell proliferation and inhibits apoptosis in colonic epithelium; the pro-inflammatory adipokine and cytokine milieu of visceral adipose tissue acting through NF-kappa B and STAT3 pathways; altered bile acid metabolism with increased secondary bile acids and microbial dysbiosis; reduced circulating adiponectin with increased leptin; and accelerated progression along the adenoma-carcinoma sequence, with obesity associated with higher rates of advanced adenoma and adenoma recurrence. Risk is amplified by concomitant metabolic syndrome and type 2 diabetes. Obesity is also associated with poorer CRC outcomes, higher rates of surgical and anaesthetic complications, and an apparent rise in early-onset CRC. Screening for CRC is by faecal immunochemical testing or colonoscopy as determined by national guidelines and individual risk, and is unaffected by weight status - obesity raises risk but is not a substitute for screening. Observational data suggest that intentional weight loss and bariatric surgery may be associated with lower CRC incidence, although evidence is less consistent than for endometrial cancer.
Key Insight
Why It Matters
Weight is one factor in bowel cancer risk, but screening is what actually saves lives, because early disease is silent. If you are 50 or older, or have a family history, ask us for a FIT kit or a colonoscopy referral - it sits alongside the weight plan, not after it.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: September 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
